Published in Aging Cell on August 06, 2007
Elevated proteasome capacity extends replicative lifespan in Saccharomyces cerevisiae. PLoS Genet (2011) 1.52
Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications. Apoptosis (2010) 1.31
A photoconvertible reporter of the ubiquitin-proteasome system in vivo. Nat Methods (2010) 1.20
Maintenance of muscle mass and load-induced growth in Muscle RING Finger 1 null mice with age. Aging Cell (2013) 1.14
EGF signalling activates the ubiquitin proteasome system to modulate C. elegans lifespan. EMBO J (2011) 1.13
Glycation-altered proteolysis as a pathobiologic mechanism that links dietary glycemic index, aging, and age-related disease (in nondiabetics). Aging Cell (2011) 1.12
Ligand-switchable substrates for a ubiquitin-proteasome system. J Biol Chem (2011) 1.11
Repression of the SUMO-specific protease Senp1 induces p53-dependent premature senescence in normal human fibroblasts. Aging Cell (2008) 1.09
The Machado-Joseph disease deubiquitylase ATX-3 couples longevity and proteostasis. Nat Cell Biol (2011) 1.08
Heat shock proteins and Drosophila aging. Exp Gerontol (2010) 1.05
Modification of ubiquitin-C-terminal hydrolase-L1 by cyclopentenone prostaglandins exacerbates hypoxic injury. Neurobiol Dis (2010) 1.02
The ubiquitin-proteasome pathway in Huntington's disease. ScientificWorldJournal (2008) 0.99
The asymmetric segregation of damaged proteins is stem cell-type dependent. J Cell Biol (2013) 0.99
Intracellular degradation of misfolded proteins in polyglutamine neurodegenerative diseases. Brain Res Rev (2008) 0.96
Molecular mechanisms of proteasome plasticity in aging. Mech Ageing Dev (2010) 0.95
PolyQ disease: misfiring of a developmental cell death program? Trends Cell Biol (2012) 0.93
Ubiquitin sets the timer: impacts on aging and longevity. Nat Struct Mol Biol (2014) 0.92
Early senescence and cell death in Arabidopsis saul1 mutants involves the PAD4-dependent salicylic acid pathway. Plant Physiol (2012) 0.90
Genetics of proteasome diseases. Scientifica (Cairo) (2013) 0.90
Normal aging modulates the neurotoxicity of mutant huntingtin. PLoS One (2009) 0.87
Mitochondrial and Ubiquitin Proteasome System Dysfunction in Ageing and Disease: Two Sides of the Same Coin? Int J Mol Sci (2015) 0.84
Endoplasmic reticulum stress in human skeletal muscle: any contribution to sarcopenia? Front Physiol (2013) 0.83
Methylglyoxal alters the function and stability of critical components of the protein quality control. PLoS One (2010) 0.83
Activation of the cAMP/PKA pathway induces UT-A1 urea transporter monoubiquitination and targets it for lysosomal degradation. Am J Physiol Renal Physiol (2013) 0.82
The cell senescence inducing gene product MORF4 is regulated by degradation via the ubiquitin/proteasome pathway. Exp Cell Res (2009) 0.82
Rab2A is a pivotal switch protein that promotes either secretion or ER-associated degradation of (pro)insulin in insulin-secreting cells. Sci Rep (2014) 0.81
Proteomic analysis of protease resistant proteins in the diabetic rat kidney. Mol Cell Proteomics (2012) 0.81
Age-dependent variability in gene expression in male Fischer 344 rat retina. Toxicol Sci (2008) 0.80
Molecular alterations in proteasomes of rat liver during aging result in altered proteolytic activities. Age (Dordr) (2013) 0.78
Pharmacology of manipulating lean body mass. Clin Exp Pharmacol Physiol (2015) 0.78
Expression profiling of the ubiquitin conjugating enzyme UbcM2 in murine brain reveals modest age-dependent decreases in specific neurons. BMC Neurosci (2015) 0.77
N-terminal acetylation and replicative age affect proteasome localization and cell fitness during aging. J Cell Sci (2014) 0.77
Healthy ageing through regulated proteostasis. EMBO J (2011) 0.76
Life and destruction: ubiquitin-mediated proteolysis in aging and longevity. F1000 Biol Rep (2010) 0.75
The ubiquitin system. Annu Rev Biochem (1998) 43.36
Structure of 20S proteasome from yeast at 2.4 A resolution. Nature (1997) 12.73
Positional cloning of the Werner's syndrome gene. Science (1996) 10.98
Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem (1996) 10.70
Mitotic misregulation and human aging. Science (2000) 8.47
Gene expression profile of aging and its retardation by caloric restriction. Science (1999) 8.06
A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3. Cell (1998) 5.78
Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr Opin Cell Biol (1995) 5.74
Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc Natl Acad Sci U S A (1999) 5.28
Selective inhibitors of the proteasome-dependent and vacuolar pathways of protein degradation in Saccharomyces cerevisiae. J Biol Chem (1996) 3.54
The multiubiquitin-chain-binding protein Mcb1 is a component of the 26S proteasome in Saccharomyces cerevisiae and plays a nonessential, substrate-specific role in protein turnover. Mol Cell Biol (1996) 3.41
Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB J (1997) 3.34
ATP hydrolysis by the proteasome regulatory complex PAN serves multiple functions in protein degradation. Mol Cell (2003) 3.14
The axial channel of the proteasome core particle is gated by the Rpt2 ATPase and controls both substrate entry and product release. Mol Cell (2001) 2.91
A proteasomal ATPase subunit recognizes the polyubiquitin degradation signal. Nature (2002) 2.86
Autocatalytic subunit processing couples active site formation in the 20S proteasome to completion of assembly. Cell (1996) 2.76
The proteasome, a novel protease regulated by multiple mechanisms. J Biol Chem (1999) 2.72
PRE2, highly homologous to the human major histocompatibility complex-linked RING10 gene, codes for a yeast proteasome subunit necessary for chrymotryptic activity and degradation of ubiquitinated proteins. J Biol Chem (1993) 2.71
Targeting of substrates to the 26S proteasome. FASEB J (1997) 2.70
Endoproteolytic activity of the proteasome. Science (2002) 2.56
Surface hydrophobic residues of multiubiquitin chains essential for proteolytic targeting. Proc Natl Acad Sci U S A (1996) 2.50
Ump1p is required for proper maturation of the 20S proteasome and becomes its substrate upon completion of the assembly. Cell (1998) 2.39
Purification of an 11 S regulator of the multicatalytic protease. J Biol Chem (1992) 2.35
Physical association of ubiquitin ligases and the 26S proteasome. Proc Natl Acad Sci U S A (2000) 2.27
ATP binding and ATP hydrolysis play distinct roles in the function of 26S proteasome. Mol Cell (2006) 2.26
RNA interference of valosin-containing protein (VCP/p97) reveals multiple cellular roles linked to ubiquitin/proteasome-dependent proteolysis. J Cell Sci (2003) 2.21
Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and 'aggresomes' during oxidative stress, aging, and disease. Int J Biochem Cell Biol (2004) 2.15
Proteasome-mediated protein processing by bidirectional degradation initiated from an internal site. Nat Struct Mol Biol (2006) 2.09
Structure of tetraubiquitin shows how multiubiquitin chains can be formed. J Mol Biol (1994) 1.76
Altered proteasome structure, function, and oxidation in aged muscle. FASEB J (2005) 1.73
Proteasome active sites allosterically regulate each other, suggesting a cyclical bite-chew mechanism for protein breakdown. Mol Cell (1999) 1.58
RECQL4, mutated in the Rothmund-Thomson and RAPADILINO syndromes, interacts with ubiquitin ligases UBR1 and UBR2 of the N-end rule pathway. Hum Mol Genet (2004) 1.56
ATP hydrolysis-dependent disassembly of the 26S proteasome is part of the catalytic cycle. Cell (2005) 1.55
Catalytic activities of the 20 S proteasome, a multicatalytic proteinase complex. Arch Biochem Biophys (2000) 1.53
Analysis of mammalian 20S proteasome biogenesis: the maturation of beta-subunits is an ordered two-step mechanism involving autocatalysis. EMBO J (1996) 1.53
Central role of the proteasome in senescence and survival of human fibroblasts: induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation. J Biol Chem (2003) 1.51
Aging perturbs 26S proteasome assembly in Drosophila melanogaster. FASEB J (2007) 1.49
Overexpression of proteasome beta5 assembled subunit increases the amount of proteasome and confers ameliorated response to oxidative stress and higher survival rates. J Biol Chem (2005) 1.43
Impairment of proteasome structure and function in aging. Int J Biochem Cell Biol (2002) 1.40
Decreased levels of proteasome activity and proteasome expression in aging spinal cord. Neuroscience (2000) 1.40
Deubiquitinating enzymes: their diversity and emerging roles. Biochem Biophys Res Commun (1999) 1.38
The proteasome in brain aging. Ageing Res Rev (2002) 1.35
PA28 activator protein forms regulatory caps on proteasome stacked rings. J Mol Biol (1994) 1.32
The Werner syndrome protein is involved in RNA polymerase II transcription. Mol Biol Cell (1999) 1.29
Oxidized protein degradation and repair in ageing and oxidative stress. FEBS Lett (2006) 1.27
Lys6-modified ubiquitin inhibits ubiquitin-dependent protein degradation. J Biol Chem (2005) 1.26
Productive RUPture: activation of transcription factors by proteasomal processing. Biochim Biophys Acta (2004) 1.19
Characterisation of the newly identified human Ump1 homologue POMP and analysis of LMP7(beta 5i) incorporation into 20 S proteasomes. J Mol Biol (2000) 1.19
Functional analysis of the proteasome regulatory particle. Mol Biol Rep (1999) 1.18
Targeted expression of dominant negative proteasome mutants in Drosophila melanogaster. Genesis (2002) 1.13
Ubiquitin in health and disease. Biochim Biophys Acta (1991) 1.10
Fibroblast cultures from healthy centenarians have an active proteasome. Exp Gerontol (2000) 1.07
Caretaker or undertaker? The role of the proteasome in aging. Mech Ageing Dev (2001) 1.03
Werner Syndrome as an example of inflamm-aging: possible therapeutic opportunities for a progeroid syndrome? Rejuvenation Res (2006) 1.02
The proteasome and its role in nuclear protein maintenance. Exp Gerontol (2007) 0.94
Proteasome inhibitors shorten replicative life span and induce a senescent-like phenotype of human fibroblasts. J Cell Physiol (2006) 0.93
Proteasome inhibition induces a senescence-like phenotype in primary human fibroblasts cultures. Biogerontology (2004) 0.92
Overexpression of hUMP1/POMP proteasome accessory protein enhances proteasome-mediated antioxidant defence. Exp Gerontol (2007) 0.89
Ubiquitin expression is up-regulated in human and rat skeletal muscles during aging. Arch Biochem Biophys (2004) 0.87
Proteasome response to interferon-gamma is altered in senescent human fibroblasts. FEBS Lett (2006) 0.87
Interference with ubiquitination causes oxidative damage and increased protein nitration: implications for neurodegenerative diseases. J Neurochem (2004) 0.86
Lysozyme degradation by the bovine multicatalytic proteinase complex (proteasome): evidence for a nonprocessive mode of degradation. Biochemistry (1999) 0.82
Age-related changes of aqueous protein profiles in rat fast and slow twitch skeletal muscles. Electrophoresis (2000) 0.81
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Aging perturbs 26S proteasome assembly in Drosophila melanogaster. FASEB J (2007) 1.49
Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications. Apoptosis (2010) 1.31
Dynamics of the degradation of ubiquitinated proteins by proteasomes and autophagy: association with sequestosome 1/p62. J Biol Chem (2011) 1.24
Inhibition of sequestosome 1/p62 up-regulation prevents aggregation of ubiquitinated proteins induced by prostaglandin J2 without reducing its neurotoxicity. Mol Cell Neurosci (2005) 1.18
It may take inflammation, phosphorylation and ubiquitination to 'tangle' in Alzheimer's disease. Neurodegener Dis (2006) 1.10
Prostaglandin J2 alters pro-survival and pro-death gene expression patterns and 26 S proteasome assembly in human neuroblastoma cells. J Biol Chem (2006) 1.08
Subchronic infusion of the product of inflammation prostaglandin J2 models sporadic Parkinson's disease in mice. J Neuroinflammation (2009) 1.05
Delta12-Prostaglandin J2 inhibits the ubiquitin hydrolase UCH-L1 and elicits ubiquitin-protein aggregation without proteasome inhibition. Biochem Biophys Res Commun (2004) 1.03
Cytoskeleton/endoplasmic reticulum collapse induced by prostaglandin J2 parallels centrosomal deposition of ubiquitinated protein aggregates. J Biol Chem (2006) 1.02
Proteasome-caspase-cathepsin sequence leading to tau pathology induced by prostaglandin J2 in neuronal cells. J Neurochem (2009) 0.98
Neurotoxic prostaglandin J2 enhances cyclooxygenase-2 expression in neuronal cells through the p38MAPK pathway: a death wish? J Neurosci Res (2004) 0.93
Neurodegeneration: linking ubiquitin/proteasome pathway impairment with inflammation. Int J Biochem Cell Biol (2003) 0.93
cAMP stimulates the ubiquitin/proteasome pathway in rat spinal cord neurons. Neurosci Lett (2012) 0.91
Prostaglandin J2 reduces catechol-O-methyltransferase activity and enhances dopamine toxicity in neuronal cells. Neurobiol Dis (2006) 0.90
Negative regulation of 26S proteasome stability via calpain-mediated cleavage of Rpn10 subunit upon mitochondrial dysfunction in neurons. J Biol Chem (2013) 0.88
A single amino acid substitution in a proteasome subunit triggers aggregation of ubiquitinated proteins in stressed neuronal cells. J Neurochem (2004) 0.88
Abeta(1-40)-induced secretion of matrix metalloproteinase-9 results in sAPPalpha release by association with cell surface APP. Neurobiol Dis (2007) 0.87
Relationship between tau pathology and neuroinflammation in Alzheimer's disease. Mt Sinai J Med (2010) 0.86
Regulating the ubiquitin/proteasome pathway via cAMP-signaling: neuroprotective potential. Cell Biochem Biophys (2013) 0.81
The Drosophila acetylcholine receptor subunit D alpha5 is part of an alpha-bungarotoxin binding acetylcholine receptor. J Biol Chem (2005) 0.76
Role of the proteasome in fly models of neurodegeneration. Methods Mol Biol (2011) 0.75